Kesimpta homecare for Belfast trust supplied by Lloyds Clinical
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct
- 20 January 2026 to 31 December 2027
Belfast Health and Social Care Trust bought ofatumumab (Kesimpta) from Lloyds Clinical as a homecare medicine. The medicine came in pre-filled pens holding 20 mg in 0.4mL, one pen to a pack.
The trust awarded the £4m contract directly, without a tender. It was due to run to December 2027 but ended in May 2026. No reason for the early end was published.
Contract ends December 2027
- What
- Homecare medicines services
- Supplier
- Lloyds Clinical
- Value
- £4m
- How it was bought
- Direct
- Dates and next
- Jan 2026 to Dec 2027